<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Barton A</submitter><funding>NIHR | NIHR Oxford Biomedical Research Centre</funding><funding>European Commission</funding><funding>Bill and Melinda Gates Foundation</funding><funding>Wellcome Trust</funding><funding>Academy of Medical Sciences</funding><pagination>e0038921</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9022534</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>90(4)</volume><pubmed_abstract>Infections with Salmonella enterica serovars Typhi and Paratyphi A cause an estimated 14 million cases of enteric fever annually. Here, the controlled nature of challenge studies is exploited to identify genetic variants associated with enteric fever susceptibility. Human challenge participants were genotyped by Illumina OmniExpress-24 BeadChip array (&lt;i>n&lt;/i> = 176) and/or transcriptionally profiled by RNA sequencing (&lt;i>n&lt;/i> = 174). While the study was underpowered to detect any single nucleotide polymorphisms (SNPs) significant at the whole-genome level, two SNPs within &lt;i>CAPN14&lt;/i> and &lt;i>MIATNB&lt;/i> were identified with &lt;i>P&lt;/i> &lt; 10&lt;sup>-5&lt;/sup> for association with development of symptoms or bacteremia following oral S. Typhi or &lt;i>S.&lt;/i> Paratyphi A challenge. Imputation of classi</pubmed_abstract><journal>Infection and immunity</journal><pubmed_title>Genetic Susceptibility to Enteric Fever in Experimentally Challenged Human Volunteers.</pubmed_title><pmcid>PMC9022534</pmcid><funding_grant_id>092661/Z/10/Z</funding_grant_id><funding_grant_id>N/A</funding_grant_id><funding_grant_id>SBF005\1134</funding_grant_id><funding_grant_id>090532/Z/09/Z</funding_grant_id><funding_grant_id>OPP1113682</funding_grant_id><funding_grant_id>OPP1084259</funding_grant_id><pubmed_authors>Camara S</pubmed_authors><pubmed_authors>Chen L</pubmed_authors><pubmed_authors>Barton A</pubmed_authors><pubmed_authors>Jones E</pubmed_authors><pubmed_authors>Blohmke CJ</pubmed_authors><pubmed_authors>Waddington C</pubmed_authors><pubmed_authors>Pollard AJ</pubmed_authors><pubmed_authors>Jones C</pubmed_authors><pubmed_authors>Dobinson H</pubmed_authors><pubmed_authors>Bibi S</pubmed_authors><pubmed_authors>Jin C</pubmed_authors><pubmed_authors>Darton TC</pubmed_authors><pubmed_authors>Gibani MM</pubmed_authors><pubmed_authors>Hill J</pubmed_authors><pubmed_authors>Shrestha S</pubmed_authors></additional><is_claimable>false</is_claimable><name>Genetic Susceptibility to Enteric Fever in Experimentally Challenged Human Volunteers.</name><description>Infections with Salmonella enterica serovars Typhi and Paratyphi A cause an estimated 14 million cases of enteric fever annually. Here, the controlled nature of challenge studies is exploited to identify genetic variants associated with enteric fever susceptibility. Human challenge participants were genotyped by Illumina OmniExpress-24 BeadChip array (&lt;i>n&lt;/i> = 176) and/or transcriptionally profiled by RNA sequencing (&lt;i>n&lt;/i> = 174). While the study was underpowered to detect any single nucleotide polymorphisms (SNPs) significant at the whole-genome level, two SNPs within &lt;i>CAPN14&lt;/i> and &lt;i>MIATNB&lt;/i> were identified with &lt;i>P&lt;/i> &lt; 10&lt;sup>-5&lt;/sup> for association with development of symptoms or bacteremia following oral S. Typhi or &lt;i>S.&lt;/i> Paratyphi A challenge. Imputation of classi</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Apr</publication><modification>2026-07-14T14:22:17.558Z</modification><creation>2025-04-06T21:48:28.131Z</creation></dates><accession>S-EPMC9022534</accession><cross_references><pubmed>35254093</pubmed><doi>10.1128/iai.00389-21</doi></cross_references></HashMap>